Profile change history

What changed for Triptorelin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Triptorelin identity.

67Total events
67Record additions
0Version changes
17Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 67 connected records →

Showing the latest 67 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00003026

PeptideScanner retained ClinicalTrials.gov record NCT00003026 at 2026-11-15T21:49:16.513Z. Its registry update date was 2012-07-02, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
July 2, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00066690

PeptideScanner retained ClinicalTrials.gov record NCT00066690 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-08-26, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
August 26, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00066703

PeptideScanner retained ClinicalTrials.gov record NCT00066703 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
February 6, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00104741

PeptideScanner retained ClinicalTrials.gov record NCT00104741 at 2026-11-15T21:49:16.513Z. Its registry update date was 2021-02-21, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
February 21, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00311636

PeptideScanner retained ClinicalTrials.gov record NCT00311636 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-06-26, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
June 26, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00659373

PeptideScanner retained ClinicalTrials.gov record NCT00659373 at 2026-11-15T21:49:16.513Z. Its registry update date was 2016-07-25, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
July 25, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00667069

PeptideScanner retained ClinicalTrials.gov record NCT00667069 at 2026-11-15T21:49:16.513Z. Its registry update date was 2025-06-05, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
June 5, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00702520

PeptideScanner retained ClinicalTrials.gov record NCT00702520 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-09-05, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
September 5, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01160315

PeptideScanner retained ClinicalTrials.gov record NCT01160315 at 2026-11-15T21:49:16.513Z. Its registry update date was 2015-10-30, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
October 30, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01467882

PeptideScanner retained ClinicalTrials.gov record NCT01467882 at 2026-11-15T21:49:16.513Z. Its registry update date was 2017-07-28, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
July 28, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01500863

PeptideScanner retained ClinicalTrials.gov record NCT01500863 at 2026-11-15T21:49:16.513Z. Its registry update date was 2016-10-26, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
October 26, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01732068

PeptideScanner retained ClinicalTrials.gov record NCT01732068 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
May 9, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01732094

PeptideScanner retained ClinicalTrials.gov record NCT01732094 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
May 9, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01764230

PeptideScanner retained ClinicalTrials.gov record NCT01764230 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-01-09, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
January 9, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02102646

PeptideScanner retained ClinicalTrials.gov record NCT02102646 at 2026-11-15T21:49:16.513Z. Its registry update date was 2015-10-28, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
October 28, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02208986

PeptideScanner retained ClinicalTrials.gov record NCT02208986 at 2026-11-15T21:49:16.513Z. Its registry update date was 2017-02-06, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
February 6, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02238366

PeptideScanner retained ClinicalTrials.gov record NCT02238366 at 2026-11-15T21:49:16.513Z. Its registry update date was 2019-07-25, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
July 25, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02400801

PeptideScanner retained ClinicalTrials.gov record NCT02400801 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-07-10, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
July 10, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03115307

PeptideScanner retained ClinicalTrials.gov record NCT03115307 at 2026-11-15T21:49:16.513Z. Its registry update date was 2020-01-27, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03169166

PeptideScanner retained ClinicalTrials.gov record NCT03169166 at 2026-11-15T21:49:16.513Z. Its registry update date was 2023-07-20, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
July 20, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04189900

PeptideScanner retained ClinicalTrials.gov record NCT04189900 at 2026-11-15T21:49:16.513Z. Its registry update date was 2019-12-11, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
December 11, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04659551

PeptideScanner retained ClinicalTrials.gov record NCT04659551 at 2026-11-15T21:49:16.513Z. Its registry update date was 2020-12-09, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
December 9, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04846218

PeptideScanner retained ClinicalTrials.gov record NCT04846218 at 2026-11-15T21:49:16.513Z. Its registry update date was 2021-11-18, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
November 18, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05896566

PeptideScanner retained ClinicalTrials.gov record NCT05896566 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-02-24, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
February 24, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05982093

PeptideScanner retained ClinicalTrials.gov record NCT05982093 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-04-24, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
April 24, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06473259

PeptideScanner retained ClinicalTrials.gov record NCT06473259 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-06-25, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
June 25, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06513962

PeptideScanner retained ClinicalTrials.gov record NCT06513962 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
August 31, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06581679

PeptideScanner retained ClinicalTrials.gov record NCT06581679 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-09-03, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
September 3, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07128394

PeptideScanner retained ClinicalTrials.gov record NCT07128394 at 2026-11-15T21:49:16.513Z. Its registry update date was 2025-08-19, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
August 19, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07816562

PeptideScanner retained ClinicalTrials.gov record NCT07816562 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-09-11, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
September 11, 2026
Evidence lane
Clinical trials
Record added

Federal Register rule 2012-25989

The Federal Register published rule 2012-25989, attributed to FDA and its parent HHS department, on 2012-10-23. Its official title is “New Animal Drugs; Approvals; Changes of Sponsor; Change of Sponsor's Name; Change of Sponsor's Address; Alfaxalone; Ivermectin and Clorsulon; Narasin; Triptorelin,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
October 23, 2012
Evidence lane
Regulatory
Record added

Federal Register notice 2015-11003

The Federal Register published notice 2015-11003, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OVUGEL,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
May 7, 2015
Evidence lane
Regulatory
Record added

Federal Register rule 2025-01226

The Federal Register published rule 2025-01226, attributed to FDA and its parent HHS department, on 2025-01-21. Its official title is “New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
January 21, 2025
Evidence lane
Regulatory
Record added

Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.

PubMed lists PMID 10099998 in Human reproduction (Oxford, England) as Clinical Trial, Journal Article, with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 13, 2019
Evidence lane
Literature metadata
Record added

Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in…

PubMed lists PMID 10372696 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Journal Article, with publication-date metadata of 1999-06 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 31, 2022
Evidence lane
Literature metadata
Record added

A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation study.

PubMed lists PMID 10525370 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, with publication-date metadata of 1999-11 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

Estrogen 'add-back' and lipid profile during GnRH agonist (triptorelin) therapy.

PubMed lists PMID 11430944 in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics as Clinical Trial, Journal Article, with publication-date metadata of 2001-07 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 22, 2019
Evidence lane
Literature metadata
Record added

[Decapeptyl (triptorelin) in the treatment of endometriosis genitalis externa].

PubMed lists PMID 11526759 in Ginekologia polska as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2001-05 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma.

PubMed lists PMID 12092661 in International urology and nephrology as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2001 (year precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 19, 2026
Evidence lane
Literature metadata
Record added

Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.

PubMed lists PMID 12147888 in Indian pediatrics as Clinical Trial, Journal Article, with publication-date metadata of 2002-07 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis.

PubMed lists PMID 14967363 in Fertility and sterility as Clinical Trial, Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, and 2 more PubMed publication types, with publication-date metadata of 2004-02 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

[Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after trea…

PubMed lists PMID 15816337 in Revue medicale de Bruxelles as Clinical Trial, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Early cessation of triptorelin in in vitro fertilization: a double-blind, randomized study.

PubMed lists PMID 15820796 in Fertility and sterility as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2005-04 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

[Pharmacodynamics of triptorelin].

PubMed lists PMID 15822863 in La Revue du praticien as Journal Article, Review, with publication-date metadata of 2005 (year precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

[Pharmacokinetics and pharmacodynamics of triptorelin].

PubMed lists PMID 16302716 in Annales d'urologie as Journal Article, Review, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2019
Evidence lane
Literature metadata
Record added

Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin.

PubMed lists PMID 17159461 in International clinical psychopharmacology as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-01 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis.

PubMed lists PMID 17178185 in European journal of obstetrics, gynecology, and reproductive biology as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2006-12-18 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

[Multicentre randomized trial comparing triptorelin medical castration versus surgical castration in the treatment of locally advanced or metastatic prostate cancer].

PubMed lists PMID 17489325 in Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-04 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 10, 2019
Evidence lane
Literature metadata
Record added

Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study.

PubMed lists PMID 19888782 in Clinical drug investigation as Clinical Trial, Phase III, Journal Article, Multicenter Study, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

Triptorelin embonate (6-month formulation).

PubMed lists PMID 20166771 in Drugs as Journal Article, Review, with publication-date metadata of 2010-02-12 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 16, 2022
Evidence lane
Literature metadata
Record added

Triptorelin embonate: a 6-month formulation for prostate cancer.

PubMed lists PMID 20969451 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2010-10-23 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.

PubMed lists PMID 22231041 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2012-01-09 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 19, 2024
Evidence lane
Literature metadata
Record added

Triptorelin in the management of prostate cancer.

PubMed lists PMID 23252566 in Future oncology (London, England) as Journal Article, Review, with publication-date metadata of 2013-01 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Triptorelin for the treatment of endometriosis.

PubMed lists PMID 24832495 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2014-06 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.

PubMed lists PMID 25990480 in Archives of gynecology and obstetrics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2015-05-20 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer.

PubMed lists PMID 27246172 in Advances in therapy as Journal Article, Review, with publication-date metadata of 2016-05-31 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 8, 2024
Evidence lane
Literature metadata
Record added

Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.

PubMed lists PMID 29177573 in Drugs as Journal Article, Review, with publication-date metadata of 2017-12 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer.

PubMed lists PMID 29551913 in Breast cancer (Dove Medical Press) as Journal Article, Review, with publication-date metadata of 2018-03-06 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 14, 2024
Evidence lane
Literature metadata
Record added

Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.

PubMed lists PMID 29957076 in Expert review of clinical pharmacology as Journal Article, Review, with publication-date metadata of 2018-07-26 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 21, 2019
Evidence lane
Literature metadata
Record added

Adolescent Gender Dysphoria in Italy: Reflections on Triptorelin, Consent, and Care.

PubMed lists PMID 40109078 in La Clinica terapeutica as Journal Article, Review, with publication-date metadata of 2025 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 14, 2025
Evidence lane
Literature metadata
Record added

A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis.

PubMed lists PMID 7781864 in European journal of obstetrics, gynecology, and reproductive biology as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-03 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 16, 2019
Evidence lane
Literature metadata
Record added

Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapept…

PubMed lists PMID 8839551 in Cancer as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1996-10-01 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

Long-acting triptorelin for the treatment of endometriosis.

PubMed lists PMID 8889631 in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics as Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 1996-09 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 22, 2019
Evidence lane
Literature metadata